Key result
High glucose promotes diabetic cardiomyopathy in T2D models by activating the Yap-miR-22-3p-Sirt1 axis.
Why the study?
Yes-associated protein (Yap) modulates cardiac remodeling and function in various cardiovascular diseases, but its role in diabetic cardiomyopathy was unclear.
Population
Mice with type 2 diabetes mellitus
Design
Animal and cellular experimental study
Authors
Loading...
Should not yet change practice in diabetic cardiomyopathy; extends evidence for Yap–miR-22-3p–Sirt1 axis as novel therapeutic target.
The Yap-miR-22-3p-Sirt1 axis plays a critical role in the pathogenesis of diabetic cardiomyopathy, offering a potential novel therapeutic target.
Li et al. (2026) studied this question. High glucose activates the Yap–miR-22-3p–Sirt1 axis, promoting diabetic cardiomyopathy by impairing myocardial structure and function in type 2 diabetes models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: